Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of fibrotic markers with diastolic function after STEMI

18 Aug 2024

Abstract excerpt

Galectin-3 and Suppression of tumorigenicity-2 (ST2) are known markers of cardiac fibrosis. We investigated the prognostic value of fibrotic markers for the development of diastolic dysfunction and long-term outcome in patients suffering an ST-elevated myocardial infarction (STEMI). We analyzed 236 patients from the GIPS-III cohort with available echocardiographic studies and plasma measurements at...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cardiac Imaging and Diagnostics
Share to Cardiac Valve Diseases and Treatments
Share to Cardiovascular Function and Risk Factors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39155333
DOI: 10.1038/s41598-024-69926-y

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of fibrotic markers with diastolic function after STEMIPMID 39155333Read ↗

The novel cardiokine GDF3 predicts adverse fibrotic remodeling post-myocardial infarctionSemantic proximity Read ↗

Galectin-3 and acute heart failure: genetic polymorphisms, plasma level, myocardial fibrosis and 1-year outcomes.Semantic proximity Read ↗

Increased C reactive protein, cardiac troponin I and GLS are associated with myocardial inflammation in patients with non-ischemic heart failure.Semantic proximity Read ↗

Type 2 diabetes worsens the outcome of ischemia/reperfusion in female STEMI patients and female db/db mice with HFpEF cardiometabolic phenotype.Semantic proximity Read ↗

IL-33 induces type-2-cytokine phenotype but exacerbates cardiac remodeling post-myocardial infarction with eosinophil recruitment, worsened systolic dysfunction, and ventricular wall rupture.Semantic proximity Read ↗

Association of circulating levels of RANTES and -403G/A promoter polymorphism to acute heart failure after STEMI and to cardiogenic shock.Semantic proximity Read ↗

Sex-Specific Impact of Diabetes Mellitus on Left Ventricular Systolic Function and Prognosis in Heart FailureSemantic proximity Read ↗

Early SGLT2 Inhibitor Therapy in Acute Coronary Syndrome: Mitigating Adverse Remodeling in High-Risk Phenotypes-A Real-World Study.Semantic proximity Read ↗

Persistent insulin resistance is associated with adverse myocardial remodeling during left ventricular assist device supportSemantic proximity Read ↗

The role of galectin-3 in patients with permanent and paroxysmal Atrial Fibrillation and echocardiographic parameters of left atrial fibrosisSemantic proximity Read ↗

Impact of Pre-percutaneous Coronary Intervention Thrombolysis in Myocardial Infarction Flow Grade in Patients With ST-segment Elevation Myocardial Infarction and Prediabetes or Diabetes After Successful Newer-generation Drug-eluting Stent ImplantationSemantic proximity Read ↗

ST2: a novel biomarker for heart failureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.